| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,951,000 |
| Market
Cap: |
228.47(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.11 - $10.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
61,710 |
101,896 |
| Total Buy Value |
$0 |
$0 |
$410,593 |
$794,229 |
| Total People Bought |
0 |
0 |
2 |
2 |
| Total Buy Transactions |
0 |
0 |
12 |
24 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ledger Steven A |
Chief Executive Officer |
• • – |
2025-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
95,730 |
95,730 |
|
- |
|
| Juvenescence Ltd |
10% Owner |
– – • |
2025-01-31 |
4 |
A |
$10.00 |
$5,000,000 |
I/I |
500,000 |
3,267,188 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2024-12-17 |
4 |
B |
$4.59 |
$17,745 |
D/D |
3,866 |
67,243 |
2.39 |
32% |
|
| Juvenescence Ltd |
10% Owner |
– – • |
2024-11-27 |
4 |
A |
$10.00 |
$5,000,000 |
I/I |
500,000 |
2,767,188 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2024-09-20 |
4 |
B |
$6.03 |
$6,851 |
D/D |
1,137 |
63,377 |
2.39 |
-29% |
|
| Bailey Gregory |
Director |
– • – |
2024-09-19 |
4 |
B |
$6.11 |
$71,384 |
D/D |
11,679 |
62,240 |
2.39 |
-23% |
|
| Bailey Gregory |
Director |
– • – |
2024-09-18 |
4 |
B |
$6.23 |
$16,873 |
D/D |
2,709 |
50,561 |
2.39 |
-23% |
|
| Mintz Steven |
Director |
– • – |
2024-09-12 |
4 |
B |
$6.47 |
$38,814 |
I/I |
6,000 |
17,443 |
2.1 |
-24% |
|
| Bailey Gregory |
Director |
– • – |
2024-08-20 |
4 |
B |
$8.25 |
$14,652 |
D/D |
1,776 |
47,582 |
2.39 |
-32% |
|
| Bailey Gregory |
Director |
– • – |
2024-08-19 |
4 |
B |
$7.93 |
$50,760 |
D/D |
6,400 |
45,806 |
2.39 |
-35% |
|
| Bailey Gregory |
Director |
– • – |
2024-08-16 |
4 |
B |
$7.31 |
$46,780 |
D/D |
6,400 |
39,406 |
2.39 |
-27% |
|
| Bailey Gregory |
Director |
– • – |
2024-08-15 |
4 |
B |
$6.65 |
$42,577 |
D/D |
6,400 |
33,006 |
2.39 |
-19% |
|
| Mintz Steven |
Director |
– • – |
2024-08-15 |
4 |
B |
$6.59 |
$50,033 |
I/I |
7,593 |
2,650 |
2.1 |
-19% |
|
| Mintz Steven |
Director |
– • – |
2024-08-15 |
4 |
B |
$6.59 |
$8,896 |
D/D |
1,350 |
12,257 |
2.39 |
-19% |
|
| Bailey Gregory |
Director |
– • – |
2024-08-14 |
4 |
B |
$7.07 |
$45,228 |
D/D |
6,400 |
26,606 |
2.39 |
-12% |
|
| Mintz Steven |
Director |
– • – |
2024-06-25 |
4 |
B |
$9.00 |
$23,400 |
D/D |
2,600 |
10,907 |
2.39 |
-18% |
|
| Mintz Steven |
Director |
– • – |
2024-06-21 |
4 |
B |
$9.50 |
$47,500 |
D/D |
5,000 |
8,307 |
2.39 |
-18% |
|
| Juvenescence Ltd |
10% Owner |
– – • |
2024-06-06 |
4 |
OE |
$13.20 |
$4,987,818 |
I/I |
377,865 |
2,267,188 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2024-05-30 |
4 |
B |
$9.50 |
$49,448 |
D/D |
5,205 |
20,206 |
2.39 |
-29% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-29 |
4 |
B |
$9.50 |
$11,144 |
D/D |
1,173 |
15,001 |
2.39 |
-27% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-28 |
4 |
B |
$9.50 |
$85,681 |
D/D |
9,019 |
13,828 |
2.39 |
-28% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-23 |
4 |
B |
$9.50 |
$22,525 |
D/D |
2,371 |
4,809 |
2.39 |
-31% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.50 |
$8,702 |
D/D |
916 |
2,438 |
2.39 |
-28% |
|
| Bailey Gregory |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.50 |
$13,509 |
D/D |
1,422 |
1,522 |
2.39 |
-28% |
|
| Mintz Steven |
Director |
– • – |
2024-05-21 |
4 |
B |
$9.75 |
$90,885 |
I/I |
9,151 |
9,900 |
2.1 |
-28% |
|
61 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.14 (2.27%) 
